Akèy › Maladi dejeneratif nè › Connecticut
Etid klinik pou Maladi dejeneratif nè nan Connecticut
4 etid pou Maladi dejeneratif nè ap chèche patisipan nan sit nan Connecticut.
Tèks ofisyèl etid la (Anglè)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #050, Stamford
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Institute For Neurodegenerative Disorders, New Haven
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785Neurologic Stem Cell Treatment Study
- MD Stem Cells, Westport
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT02795052Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.